Premier Biomedical, Inc. has acquired exclusive licenses for patent-pending medications/medical procedures to develop cures for a significant number of the most debilitating and often fatal illnesses affecting mankind: , , , , Alzheimer’s Disease, , and . They have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. They also have initiated the development of potential patient trial application lists. They have a management team with extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment. Their extensive contacts in the medical/pharmaceutical industries will ensure that new developments will achieve maximum visibility and exposure to the market. Transparency and accountability will continue to be ensured via regular issuance of technical progress reports, financials, and investor relations reports to maintain investor enthusiasm.

http://www.premierbiomedical.com

Tags